Evidence map›Paper›PMID 41221536›Full record

ReviewBiomedical reports2025

Applications of machine learning and deep learning in precision medicine: Opportunities and challenges in genomics, oncology and clinical integration (Review).

Qiang Zhao, Guangxin Li, Kunpeng Du

Abstract readReview
In one paragraph

Review in Biomedical reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qiang ZhaoCenter for Precision Cancer Medicine and Translational Research, Tianjin Cancer Hospital Airport Hospital, Tianjin 300308, P.R. China.
Guangxin LiDepartment of Pathology, Chongqing University Cancer Hospital, Chongqing 400042, P.R. China.
Kunpeng DuDepartment of Radiation Oncology, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong 510282, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the advancement of precision medicine, machine learning (ML) and deep learning have increasingly become a pivotal tool for driving medical innovation. Precision medicine, grounded in individual variability, aims to deliver personalized treatment interventions, with ML serving as a critical enabler for achieving this goal. Recent ML-driven progress in genomic analysis, personalized treatment optimization and disease diagnostics have significantly elevated the accuracy and efficacy of medical decision-making processes. However, the widespread adoption of artificial intelligence also faces multifaceted challenges, including data privacy frameworks, cybersecurity risks, ethical considerations and the integration of technology with clinical workflows. The present review seeks to analyze cutting-edge applications of ML within precision medicine domains, examine its challenges, and project future evolutionary pathways, emphasizing the critical need for proactive attention to these issues to ensure tangible benefits for patients and healthcare systems.

Indexed as

genomic analysismachine learningmedical challengespersonalized treatmentprecision medicine

Identifiers

PMID41221536
PMCPMC12598536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.